» Articles » PMID: 23021215

Transcriptional Amplification in Tumor Cells with Elevated C-Myc

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2012 Oct 2
PMID 23021215
Citations 905
Authors
Affiliations
Soon will be listed here.
Abstract

Elevated expression of the c-Myc transcription factor occurs frequently in human cancers and is associated with tumor aggression and poor clinical outcome. The effect of high levels of c-Myc on global gene regulation is poorly understood but is widely thought to involve newly activated or repressed "Myc target genes." We report here that in tumor cells expressing high levels of c-Myc the transcription factor accumulates in the promoter regions of active genes and causes transcriptional amplification, producing increased levels of transcripts within the cell's gene expression program. Thus, rather than binding and regulating a new set of genes, c-Myc amplifies the output of the existing gene expression program. These results provide an explanation for the diverse effects of oncogenic c-Myc on gene expression in different tumor cells and suggest that transcriptional amplification reduces rate-limiting constraints for tumor cell growth and proliferation.

Citing Articles

PROTACs coupled with oligonucleotides to tackle the undruggable.

Zhang G, Yan S, Liu Y, Du Z, Min Q, Qin S Bioanalysis. 2025; 17(4):261-276.

PMID: 39895280 PMC: 11864318. DOI: 10.1080/17576180.2025.2459528.


Super-enhancers in tumors: unraveling recent advances in their role in Oncogenesis and the emergence of targeted therapies.

Ji Y, Li B, Lin R, Yuan J, Han Y, Du Y J Transl Med. 2025; 23(1):98.

PMID: 39838405 PMC: 11753147. DOI: 10.1186/s12967-025-06098-x.


The Functional Interaction Between Epstein-Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma.

Solares S, Leon J, Garcia-Gutierrez L Cancers (Basel). 2025; 16(24.

PMID: 39766110 PMC: 11674381. DOI: 10.3390/cancers16244212.


Study of the Anti-MYC Potential of Lanostane-Type Triterpenes.

Oliveira J, Negreiro J, Nunes F, Barbosa F, Mafezoli J, Mattos M ACS Omega. 2025; 9(51):50844-50858.

PMID: 39741863 PMC: 11683602. DOI: 10.1021/acsomega.4c10201.


ZNF143 binds DNA and stimulates transcription initiation to activate and repress direct target genes.

Dong J, Sathyan K, Scott T, Mukherjee R, Guertin M Nucleic Acids Res. 2024; 53(2.

PMID: 39676670 PMC: 11754675. DOI: 10.1093/nar/gkae1182.


References
1.
Schlosser I, Holzel M, Hoffmann R, Burtscher H, Kohlhuber F, Schuhmacher M . Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line. Oncogene. 2004; 24(3):520-4. DOI: 10.1038/sj.onc.1208198. View

2.
Li Z, Van Calcar S, Qu C, Cavenee W, Zhang M, Ren B . A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci U S A. 2003; 100(14):8164-9. PMC: 166200. DOI: 10.1073/pnas.1332764100. View

3.
Ruggero D . The role of Myc-induced protein synthesis in cancer. Cancer Res. 2009; 69(23):8839-43. PMC: 2880919. DOI: 10.1158/0008-5472.CAN-09-1970. View

4.
Zhang Y, Liu T, Meyer C, Eeckhoute J, Johnson D, Bernstein B . Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008; 9(9):R137. PMC: 2592715. DOI: 10.1186/gb-2008-9-9-r137. View

5.
Zhou Q, Li T, Price D . RNA polymerase II elongation control. Annu Rev Biochem. 2012; 81:119-43. PMC: 4273853. DOI: 10.1146/annurev-biochem-052610-095910. View